Case Summary:

A senior research associate from China specializing in biotechnology successfully obtained an EB-2 National Interest Waiver (NIW) with the legal support of the North America Immigration Law Group. Her work focuses on using advanced in vitro functional approaches to study disease mechanisms and identify drug targets for developing new treatments for cancer, obesity, and autoimmune disorders. Among its many applications, her research plays a key role in advancing personalized cancer treatments by identifying precise drug targets.

Recognizing the significance of her contributions, we took on her case to highlight her achievements. She holds an MS in biology and is a recognized professional in her field. Her research met the Matter of Dhanasar criteria for a national interest waiver, as it is of substantial merit and national importance.

We emphasized that her work is vital in reducing the physical, emotional, and financial burdens of cancer by improving the understanding of the disease at the cellular level. To strengthen her petition, we detailed her notable track record and impact on the field:

• She has authored 3 peer-reviewed journal articles and 1 preprint in respected scientific journals.
• Her publications have been cited 12 times by other researchers, demonstrating her influence in the field.
• She received strong endorsements from independent experts, confirming the significance of her research. To support her petition, we included four recommendation letters from independent experts, documentation of her publications, memberships in prestigious organizations, and references to discussions of her work by other researchers. One expert highlighted her contributions, stating:

“[Client] has quickly become a leading researcher in biotechnology due to her expertise in immunology, targeted protein degraders, and in vitro functional studies. Her work addresses critical challenges in cancer and autoimmune disease treatment, including developing therapies for previously untreatable targets and improving immune regulation. It is clear that she is making a significant impact in biotechnology.”

Her study has even received funding from the National Heart, Lung, and Blood Institute (NHLBI), the Crohn’s & Colitis Foundation, the Marie Skłodowska-Curie Actions program (MSCA), and the Juvenile Diabetes Research Foundation (JDRF). This funding supports projects that advance biomedical research intending to improve the diagnosis, treatment, and prevention of cardiovascular, respiratory, autoimmune, and metabolic diseases.

Therefore, our client’s research offers treatments for autoimmune diseases such as colitis and diabetes while enhancing overall immune system regulation.

Her research provides valuable insights for the medical community and contributes to advancements in healthcare in the United States. Without her continued work, efforts to address pressing public health challenges would be significantly hindered. As a result, USCIS approved her NIW petition in just seven days after reviewing the submission. We are delighted with this outcome and wish our client continued success in her career.